Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Richman

Showing results (401-410 of 792) with videos related to

Pageof 80
Sort By:
Journal of Virology|February 28, 2006
Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasmaEloisa Yuste, Hannah B Sanford, Jill Carmody, et al.
Annals of Neurology|April 1, 1993
Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials GroupJ J Sidtis, C Gatsonis, R W Price, et al.
The New England Journal of Medicine|October 11, 1990
A pilot study of low-dose zidovudine in human immunodeficiency virus infectionA C Collier, S Bozzette, R W Coombs, et al.
The Journal of Infectious Diseases|August 22, 2013
Virologic correlates of anti-CMV IgG levels in HIV-1-infected menSara Gianella, Sheldon R Morris, Erick Tatro, et al.
The Journal of Infectious Diseases|April 20, 2013
Using ultradeep pyrosequencing to study HIV-1 coreceptor usage in primary and dual infectionGabriel A Wagner, Mary E Pacold, Edgar Vigil, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-55389AM L Smidt, K E Potts, S P Tucker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Dynamics of T cell responses in HIV infectionVictor Appay, Laura Papagno, Celsa A Spina, et al.
Nature Medicine|June 1, 1996
HIV viral load markers in clinical practiceM S Saag, M Holodniy, D R Kuritzkes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2008
Herpes simplex virus type 2 acquisition during recent HIV infection does not influence plasma HIV levelsEdward R Cachay, Simon D W Frost, Art F Y Poon, et al.
Antiviral Research|September 8, 2015
Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latencyCory H White, Harvey E Johnston, Bastiaan Moesker, et al.
Pageof 80

Showing results (401-410 of 792) with videos related to

Sort By:
Pageof 80
Journal of Virology|February 28, 2006
Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasmaEloisa Yuste, Hannah B Sanford, Jill Carmody, et al.
Annals of Neurology|April 1, 1993
Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials GroupJ J Sidtis, C Gatsonis, R W Price, et al.
The New England Journal of Medicine|October 11, 1990
A pilot study of low-dose zidovudine in human immunodeficiency virus infectionA C Collier, S Bozzette, R W Coombs, et al.
The Journal of Infectious Diseases|August 22, 2013
Virologic correlates of anti-CMV IgG levels in HIV-1-infected menSara Gianella, Sheldon R Morris, Erick Tatro, et al.
The Journal of Infectious Diseases|April 20, 2013
Using ultradeep pyrosequencing to study HIV-1 coreceptor usage in primary and dual infectionGabriel A Wagner, Mary E Pacold, Edgar Vigil, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-55389AM L Smidt, K E Potts, S P Tucker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Dynamics of T cell responses in HIV infectionVictor Appay, Laura Papagno, Celsa A Spina, et al.
Nature Medicine|June 1, 1996
HIV viral load markers in clinical practiceM S Saag, M Holodniy, D R Kuritzkes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2008
Herpes simplex virus type 2 acquisition during recent HIV infection does not influence plasma HIV levelsEdward R Cachay, Simon D W Frost, Art F Y Poon, et al.
Antiviral Research|September 8, 2015
Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latencyCory H White, Harvey E Johnston, Bastiaan Moesker, et al.
Pageof 80